Based on the aforementioned results, the enhanced tumor‐killing effect of the system compared to PTX or PFKFB4 inhibition alone can be attributed to the increased sensitivity of SCLC to PTX upon PFKFB4 downregulation. This evidence concerns the gene PFKFB4 and small cell lung carcinoma.